Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer-Reference-Cited by-同舟云学术

Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer

Published:2014-08-24 Issue:7525 Volume:515 Page:134-137
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Di Mitri Diletta,Toso Alberto,Chen Jing Jing,Sarti Manuela,Pinton Sandra,Jost Tanja Rezzonico,D’Antuono Rocco,Montani Erica,Garcia-Escudero Ramon,Guccini Ilaria,Da Silva-Alvarez Sabela,Collado Manuel,Eisenberger Mario,Zhang Zhe,Catapano Carlo,Grassi Fabio,Alimonti Andrea

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature13638.pdf

Reference31 articles.

1. Collado, M. & Serrano, M. Senescence in tumours: evidence from mice and humans. Nature Rev. Cancer 10, 51–57 (2010)

2. Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725–730 (2005)

3. Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660–665 (2005)

4. Tasdemir, N. & Lowe, S. W. Senescent cells spread the word: non-cell autonomous propagation of cellular senescence. EMBO J. 32, 1975–1976 (2013)

5. Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nature Cell Biol. 15, 978–990 (2013)

Cited by 298 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives;International Immunopharmacology;2024-12

2. Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging;Science Translational Medicine;2024-09-11

3. Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes;Clinical and Translational Medicine;2024-09

4. Deciphering the predictive value of senescence-related signature in lung adenocarcinoma: Implications for antitumor immunity and immunotherapy efficacy;Heliyon;2024-08

5. Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer;Cancer Letters;2024-08